Cefixime

Overview

Cefixime is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1541).

API suppliers (12)

Suppliers of Cefixime backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Lupin LimitedIndia1 active DMF
• Lupin LimitedIndia1 active DMF
• PURE AND CURE HEALTHCARE PRIVATE LTDIndia1 active DMF
• Lupin LimitedIndia1 active DMF
• Nectar Lifesciences LimitedIndia1 active DMF
• Lupin LimitedIndia1 active DMF
• Nectar Lifesciences LimitedIndia1 active DMF
• Nectar Lifesciences LimitedIndia1 active DMF
• PURE AND CURE HEALTHCARE PRIVATE LTDIndia1 active DMF
• Astellas Pharma Inc.Japan
• LEDERLE LABORATORIES
• SANDOZ PRIVATE LTD

Patent & exclusivity (US)

Per the FDA Orange Book (15 approved US products), the latest listed US patent on Cefixime expires 14 Dec 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Canonical SMILES

C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O

InChIKey

OKBVVJOGVLARMR-QSWIMTSFSA-N